๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Hormonal treatment of advanced breast cancer. A randomized trial of tamoxifen Versus nandrolone decanoate

โœ Scribed by Pirkko Kellokumpu-Lehtinen; Riikka Huovinen; Risto Johansson


Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
476 KB
Volume
60
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A prospective randomized trial of doxoru
โœ Massimo Lopez; Alma Contegiacomo; Patrizia Vici; Concetta Dello Ioio; Luigi Di L ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 481 KB ๐Ÿ‘ 2 views

Seventy-six patients with advanced breast cancer were entered into the current study. They were randomized to receive either idarubicin (IDA) 45 mg/m2 orally or doxorubicin (DX) 75 mg/m2 intravenously (IV), both drugs being administered every 3 weeks. Among 37 evaluable patients who received DX trea

Telephone counseling of breast cancer pa
โœ Alfred C. Marcus; Kathleen M. Garrett; David Cella; Lari B. Wenzel; Marianne J. ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 203 KB ๐Ÿ‘ 1 views

The Telephone Counseling Trial for Breast Cancer Survivors is a randomized, controlled study designed to test the impact of a telephone-based counseling intervention on quality of life of early-stage breast cancer patients who have completed adjuvant treatment. A psychoeducational counseling model i

A randomized trial of tamoxifen alone or
โœ James N. Ingle; Vera J. Suman; Carl G. Kardinal; James E. Krook; James A. Mailli ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 110 KB ๐Ÿ‘ 2 views

## BACKGROUND. Tamoxifen (TAM) is generally considered the hormonal agent of choice for postmenopausal women with hormone receptor positive breast carcinoma. The somatostatin analogues, including octreotide, have demonstrated inhibition of breast carcinoma cell lines and multiple endocrinologic act